Dr. Brendan Carvalho shares insights from a study comparing Accuro’s accuracy to other ultrasound devices for neuraxial anesthesia. He explains how both Accuro and larger ultrasound systems reliably predict the point of loss of resistance, particularly in patients with challenging anatomy, such as those with obesity, scoliosis, or previous spine surgery. Dr. Carvalho highlights Accuro’s key advantages, including its portability, 3D navigation, and unique skin-marking feature, which together enhance precision and usability in both clinical and teaching environments.
Recent Posts
- RIVANNA nominated for MedTech Scale-Up of the Year at MedTech World Awards 2026 | North America
- RIVANNA’s Accuro XV Demonstrates Feasibility of Musculoskeletal Imaging by Non-physician Users With Minimal Training
- RIVANNA expands multi-site clinical study for Accuro XV musculoskeletal imaging system
- Neuraxial Anesthesia: What is State of the Art in 2026?
- The Future of Neuraxial Anesthesia
